Swiss Tropical and Public Health Institute, Basel, Switzerland ; University of Basel, Basel, Switzerland.
PLoS One. 2013 Sep 27;8(9):e76316. doi: 10.1371/journal.pone.0076316. eCollection 2013.
Carriage and density of gametocytes, the transmission stages of malaria parasites, are determined for predicting the infectiousness of humans to mosquitoes. This measure is used for evaluating interventions that aim at reducing malaria transmission. Gametocytes need to be detected by amplification of stage-specific transcripts, which requires RNA-preserving blood sampling. For simultaneous, highly sensitive quantification of both, blood stages and gametocytes, we have compared and optimized different strategies for field and laboratory procedures in a cross sectional survey in 315 5-9 yr old children from Papua New Guinea. qRT-PCR was performed for gametocyte markers pfs25 and pvs25, Plasmodium species prevalence was determined by targeting both, 18S rRNA genes and transcripts. RNA-based parasite detection resulted in a P. falciparum positivity of 24.1%; of these 40.8% carried gametocytes. P. vivax positivity was 38.4%, with 38.0% of these carrying gametocytes. Sensitivity of DNA-based parasite detection was substantially lower with 14.1% for P. falciparum and 19.6% for P. vivax. Using the lower DNA-based prevalence of asexual stages as a denominator increased the percentage of gametocyte-positive infections to 59.1% for P. falciparum and 52.4% for P. vivax. For studies requiring highly sensitive and simultaneous quantification of sexual and asexual parasite stages, 18S rRNA transcript-based detection saves efforts and costs. RNA-based positivity is considerably higher than other methods. On the other hand, DNA-based parasite quantification is robust and permits comparison with other globally generated molecular prevalence data. Molecular monitoring of low density asexual and sexual parasitaemia will support the evaluation of effects of up-scaled antimalarial intervention programs and can also inform about small scale spatial variability in transmission intensity.
配子体的携带率和密度是疟疾寄生虫的传播阶段,用于预测人类对蚊子的感染性。这种方法用于评估旨在减少疟疾传播的干预措施。配子体需要通过扩增阶段特异性转录本来检测,这需要保存 RNA 的血液采样。为了同时对血液期和配子体进行高度敏感的定量,我们在巴布亚新几内亚的 315 名 5-9 岁儿童的横断面调查中比较和优化了现场和实验室程序的不同策略。qRT-PCR 用于检测配子体标志物 pfs25 和 pvs25,通过靶向 18S rRNA 基因和转录本来确定疟原虫种的流行率。基于 RNA 的寄生虫检测导致恶性疟原虫阳性率为 24.1%;其中 40.8%携带配子体。间日疟原虫阳性率为 38.4%,其中 38.0%携带配子体。基于 DNA 的寄生虫检测的敏感性要低得多,恶性疟原虫为 14.1%,间日疟原虫为 19.6%。使用基于 DNA 的无性阶段较低的流行率作为分母,将恶性疟原虫和间日疟原虫的配子体阳性感染率分别提高到 59.1%和 52.4%。对于需要高度敏感和同时定量检测性和无性寄生虫阶段的研究,18S rRNA 转录本检测可以节省工作和成本。基于 RNA 的阳性率明显高于其他方法。另一方面,基于 DNA 的寄生虫定量是稳健的,并允许与全球生成的其他分子流行数据进行比较。对低密度无性和有性寄生虫血症的分子监测将支持评估扩大规模的抗疟干预计划的效果,并且还可以了解传播强度的小范围空间变异性。